Advanced Search

 

Study ID Status Title Patient Level Data
270362/006 Completed A phase III, open, randomized, multicentric study to compare the reactogenicity and immunogenicity of GSK Biologicals’ combined Vi polysaccharide typhoid vaccine and inactivated Hepatitis A vaccine, to that elicited by GSK Biologicals’ Hepatitis A vaccine, administered singly or concomitantly with GSK Biologicals’ Vi polysaccharide vaccine Study Listed on ClinicalStudyDataRequest.com
270362/010 Completed A phase IV, open study of re-vaccination with GSK Biologicals’ Vi polysaccharide typhoid vaccine in subjects, who were previously administered a primary vaccination with GSK Biologicals’ combined Vi polysaccharide typhoid and inactivated hepatitis A vaccine or with GSK Biologicals’ Vi polysaccharide typhoid vaccine
275833/030 Completed Protocol SB-275833/030 – Studies 030A and 030B: Two Identical Double-blind, Double-dummy, Multicenter, Comparative Phase III Studies of the Safety and Efficacy of Topical 1% SB-275833, Applied Twice Daily, versus Oral Cephalexin, 500mg in Adults, or 12.5mg/kg (250mg/5ml) in Children, Twice Daily, in the Treatment of Uncomplicated Secondarily Infected Traumatic Lesions (SITL). Study Listed on ClinicalStudyDataRequest.com
275833/032 Completed A Randomized, Double-blind, Double-Dummy, Multicenter, Non-inferiority Phase III Study to Assess the Safety and Efficacy of Topical SB-275833 Ointment, 1%, Applied Twice Daily Study Listed on ClinicalStudyDataRequest.com
29060/001/081 Completed An Open Pharmacokinetic and Pharmacodynamic Study of Paroxetine (20mg, 30mg, or 40mg daily) in the Treatment of Major Depressive Disorder (DSM III)
29060/004 Completed A Double-Blind Extension of Protocol PAR 03
29060/005 Completed A Open-label Long-term Evaluation of Paroxetine in Depressed Outpatients
29060/005_3 Completed An Investigation of the Pharmacokinetics of Paroxetine in Geriatric Patients with Depression
29060/008 Completed An Open-label, Single-dose, Five-period Crossover Evaluation of the Pharmacokinetic Properties of Paroxetine When Administered by Oral Route
29060/009 Completed A Multicenter, Double-blind, Placebo-controlled Fixed-dose Evaluation of Four Doses of Paroxetine Study Listed on ClinicalStudyDataRequest.com
29060/01/001 Completed A Phase II, Placebo-Controlled, Double-Blind Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/010 Completed A multiple-dose, steady-state design pharmacokinetic evaluation of the interaction between paroxetine and diazepam
29060/011 Completed Two Combined Multi-Center, Doxepin-Controlled, Double-Blind Studies of Paroxetine in Geriatric Outpatients with Major Depressive Disorder
29060/012 Completed A Placebo-controlled, single-dose, five-period crossover evaluation of the pharmacokinetic properties of paroxetine when administered by the oral route
29060/012/280 Completed An Investigation of the Efficacy and Tolerance of Paroxetine in an Open Study of Patients with Depression and Obsessive Compulsive Disorder
29060/012_3 Completed A Study to Assess the Effectiveness and Tolerance of Paroxetine by Double-Blind Comparison with Placebo and Mianserin Study Listed on ClinicalStudyDataRequest.com
29060/013 Completed A multiple-dose, steady-state design, pharmacokinetic evaluation of the interaction between paroxetine and cimetidine
29060/014 Completed A multiple-dose, steady-state design, pharmacokinetic evaluation of the interaction between paroxetine and warfarin
29060/015 Completed A multiple-dose, steady-state design, pharmacokinetic evaluation of the interaction between paroxetine and digoxin
29060/016 Completed A multiple dose, steady-state, cross-over, replicate-sample evaluation of the bioequivalence of a tablet and capsule formulation of paroxetine.
29060/02/001 Completed A Double-Blind, Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/02/002 Completed A Double-Blind, Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/02/003 Completed A Double-Blind, Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/02/004 Completed A Double-Blind, Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/020 Completed An Interim Report of a Study to Assess the Effectiveness and Tolerance of Paroxetine in Depressed Patients by Double-Blind Comparison with Mianserin

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.